[{"id":"950fcf2e-4074-44cd-a0af-d38d8af8ef4c","acronym":"","url":"https://clinicaltrials.gov/study/NCT02939807","created_at":"2021-01-18T14:26:07.024Z","updated_at":"2024-07-02T16:36:55.737Z","phase":"Phase 2","brief_title":"A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma","source_id_and_acronym":"NCT02939807","lead_sponsor":"Medical University of South Carolina","biomarkers":" MYC","pipe":"","alterations":" ","tags":["MYC"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e sorafenib • Yeliva (opaganib)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 09/30/2019","start_date":" 09/30/2019","primary_txt":" Primary completion: 09/30/2023","primary_completion_date":" 09/30/2023","study_txt":" Completion: 01/30/2024","study_completion_date":" 01/30/2024","last_update_posted":"2019-09-12"},{"id":"c5e874c6-c32f-4511-a6ed-b48b2e117537","acronym":"","url":"https://clinicaltrials.gov/study/NCT02229981","created_at":"2021-01-29T07:07:01.952Z","updated_at":"2024-07-02T16:37:15.746Z","phase":"Phase 1/2","brief_title":"Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma","source_id_and_acronym":"NCT02229981","lead_sponsor":"RedHill Biopharma Limited","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Yeliva (opaganib)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 07/01/2014","start_date":" 07/01/2014","primary_txt":" Primary completion: 06/01/2019","primary_completion_date":" 06/01/2019","study_txt":" Completion: 12/01/2019","study_completion_date":" 12/01/2019","last_update_posted":"2017-12-07"}]